APS |
SH2B2, APS: SH2B adapter protein 2 |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
149.000 |
Evidence |
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
149.000 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
149.000 |
Evidence |
|
DRD1 |
DRD1: D(1A) dopamine receptor |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
149.000 |
Evidence |
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
DRD1 |
DRD1: D(1A) dopamine receptor |
149.000 |
Evidence |
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
BMX |
IPI00514142 |
149.000 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
149.000 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
149.000 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
149.000 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
149.000 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
149.000 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
149.000 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
149.000 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
SHC4 |
SHC-transforming protein 4 |
149.000 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
SHC4 |
SHC-transforming protein 4 |
149.000 |
Evidence |
|
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
SHC4 |
SHC-transforming protein 4 |
149.000 |
Evidence |
|
EFNA2 |
EFNA2, EPLG6, LERK6: Ephrin-A2 precursor |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
149.000 |
Evidence |
|
VAMP4 |
VAMP4: Vesicle-associated membrane protein 4 |
STX3A |
STX3, STX3A: Syntaxin-3 |
149.000 |
Evidence |
|
EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
PSMC1 |
PSMC1: 26S protease regulatory subunit 4 |
149.000 |
Evidence |
|
SNAP25 |
SNAP25, SNAP: Synaptosomal-associated protein 25 |
STX1A |
STX1A, STX1: Syntaxin-1A |
148.000 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
148.000 |
Evidence |
|
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
148.000 |
Evidence |
|
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
148.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
148.000 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
148.000 |
Evidence |
|